Gabapentin Capsule
Product Images NDC 76282-321

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76282-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image100mg (Gabapentin Capsules 100mg)

Label for Gabapentin Capsules, USP 100 mg by Exelan Pharmaceuticals, Inc. The label states the pharmacist should dispense with the attached medication guide. The package contains 90 capsules. Storage conditions and manufacturer information (InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc.) are noted. The label includes an NDC number and a barcode.*

FDA Label Image

Gabapentin Capsules 300mg 1

Label for Gabapentin Capsules, USP 300 mg oral capsules. The label includes dispensing instructions, storage temperature guidance, and manufacturing information. It specifies 90 capsules per container, with Exelan Pharmaceuticals, Inc. as the labeler and InvaGen Pharmaceuticals, Inc. as the manufacturer. The NDC is 76282-322-90.*

FDA Label Image

Gabapentin Capsules 300mg 2

Label for Gabapentin Capsules, USP 300 mg by Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-627-90, the dosage strength 300 mg, and the package count of 90 capsules. It instructs pharmacists to dispense with an attached medication guide and provides storage and manufacturing information.*

FDA Label Image

Image400mg (Gabapentin Capsules 400mg)

Label for Gabapentin Capsules, USP, 400 mg, oral capsules by Exelan Pharmaceuticals, Inc. The label indicates the product is prescription-only and contains 90 capsules. It includes storage instructions, manufacturer information for InvaGen Pharmaceuticals, Inc., and a barcode with a QR code.*

FDA Label Image

Figure 1 (Gabapentin Capsules Fig01)

A line graph showing mean pain scores over 8 weeks comparing placebo to Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin scores decrease over time, while placebo scores remain relatively stable.*

FDA Label Image

Figure 2 (Gabapentin Capsules Fig02)

A line graph showing mean pain scores over a 7-week period, comparing placebo with gabapentin at 1800 mg/day and 2400 mg/day. The x-axis represents weeks divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain score values from 0 to 10. Both gabapentin doses show decreasing pain scores over time compared to placebo.*

FDA Label Image

Figure 3 (Gabapentin Capsules Fig03)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing response rates in two studies. Study 1 compares placebo (12%) and GBP 3600 (29%). Study 2 compares placebo (14%) with GBP 1800 (32%) and GBP 2400 (34%). Statistical significance markers indicate p-values less than 0.01 and 0.001 respectively.*

FDA Label Image

Figure 4 (Gabapentin Capsules Fig04)

A scatter plot graph showing the percentage difference on the y-axis versus daily dose in mg on the x-axis for gabapentin. The graph compares three studies labeled 'a', 'b', and 'c' with markers in black, gray, and white respectively, illustrating the difference percentages at various daily doses ranging from around 600 to 1800 mg.*

FDA Label Image

Formula (Gabapentin Capsules Formula)

This image displays a formula for calculating creatinine clearance (CLCr). The formula uses patient age in years, weight in kilograms, serum creatinine level in mg/dL, and applies a multiplication factor of 0.85 for female patients, reflecting renal function assessment metrics.*

FDA Label Image

Structural Formula (Gabapentin Capsules Str)

Chemical structure of gabapentin showing a cyclohexane ring attached to a carbon with amino and carboxylic acid functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.